5 research outputs found

    Peer-assisted Information-Centric Network (PICN): A Backward Compatible Solution

    Get PDF
    International audienceInformation-Centric Networking (ICN) is a promising solution for most of Internet applications where the content represents the core of the application. However, the proposed solutions for the ICN architecture are associated with many complexities including pervasive caching in the Internet and incompatibility with legacy IP networks, so the deployment of ICN in real networks is still an open problem. In this paper, we propose a backward compatible ICN architecture to address the caching issue in particular. The key idea is implementing edge caching in ICN, using a coalition of end clients and edge servers. Our solution can be deployed in IP networks with HTTP requests. We performed a trace-driven simulation for analyzing PICN benefits using IRCache and Berkeley trace files. The results show that in average, PICN decreases the latency for 78% and increases the content retrieval speed for 69% compared to a direct download from the original web servers. When comparing PICN with a solution based on central proxy servers, we show that the hit ratio obtained using a small cache size in each PICN client is almost 14% higher than the hit ratio obtained with a central proxy server using an unlimited cache storage

    CN2F: A Cloud-Native Cellular Network Framework

    Full text link
    Upcoming 5G and Beyond 5G (B5G) cellular networks aim to improve the efficiency and flexibility of mobile networks by incorporating various technologies, such as Software Defined Networking (SDN), Network Function Virtualization (NFV), and Network Slicing (NS). In this paper, we share our findings, accompanied by a comprehensive online codebase, about the best practice of using different open-source projects in order to realize a flexible testbed for academia and industrial Research and Development (R&D) activities on the future generation of cellular networks. In particular, a Cloud-Native Cellular Network Framework (CN2F) is presented which uses OpenAirInterface's codebase to generate cellular Virtual Network Functions (VNFs) and deploys Kubernetes to disperse and manage them among some worker nodes. Moreover, CN2F leverages ONOS and Mininet to emulate the effect of the IP transport networks in the fronthaul and backhaul of real cellular networks. In this paper, we also showcase two use cases of CN2F to demonstrate the importance of Edge Computing (EC) and the capability of Radio Access Network (RAN) slicing

    International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

    No full text
    We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN
    corecore